Continuing trends in pathological stage migration in radical prostatectomy specimens

Urologic Oncology: Seminars and Original Investigations

Volumn 22, Issue 4, 2004, Pages 300-306

  Derweesh, Ithaar H ^a   Kupelian, Patrick A ^b   Zippe, Craig ^a   Levin, Howard S ^a   Brainard, Jennifer ^a   Magi Galluzzi, Cristina ^a   Myles, Jonathan ^a   Reuther, Alwyn M ^a   Klein, Eric A ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b M D ANDERSON CANCER CENTER ORLANDO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADJUVANT THERAPY; ADULT; ARTICLE; CANCER SCREENING; CANCER STAGING; CANCER SURVIVAL; CHEMICAL ANALYSIS; CONTROLLED STUDY; HORMONAL THERAPY; HUMAN; KAPLAN MEIER METHOD; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER; PROSTATECTOMY; RECURRENCE RISK; SCORING SYSTEM; TREATMENT OUTCOME; TUMOR BIOPSY; UNITED STATES;

AGED; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PROGNOSIS; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 3342919364     PISSN: 10781439     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.urolonc.2003.11.011     Document Type: Article

References (38)

1. Catalona W.J., Richie J.P., Ahmann F.R., et al. Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer results of a multicenter clinical trial of 6,630 men. J Urol. 151:1994;1283-1290
2. Catalona W.J., Smith D.S., Ratliff T.L., et al. Detection of organ confined prostate cancer is increased through prostate-specific antigen based screening. JAMA. 270:1993;948-954
3. Mettlin C., Murphy G.P., Lee F., et al. Characteristics of prostate cancers detected in a multimodality early detection program. Cancer. 72:1993;1701-1708
4. Carter H.B., Pearsonn J.D., Metter J.E., et al. Longitudinal evaluation of prostate specific antigen levels in men with and without prostate disease. JAMA. 267:1992;2215-2220
5. Helzlsouer K.J., Newby J., Comstock G.W. Prostate-specific antigen levels and subsequent prostate cancer Potential for screening. Cancer Epidemiol Biomarkers Prev. 1:1992;537-540
6. Stenman U.H., Hakama M., Knekt P., et al. Serum concentrations of prostate specific antigen and its complex with alpha 1-antichymotrypsin before diagnosis of prostate cancer. Lancet. 344:1994;1594-1598
7. Gann P.H., Hennekens C.H., Stampher M.J. A prospective evaluation of plasma prostate-specific antigen for detection of prostate cancer. JAMA. 273:1995;289-294
8. Tibblin G., Welin L., Bergstrom R., et al. The value of prostate specific antigen in early diagnosis of prostate cancer The study of men born in 1913. J Urol. 154:1995;1386-1389
9. Stamey T.A., Donaldson A.N., Yemoto C.E., et al. Histological and clinical findings in 896 consecutive prostates treated only with radical retropubic prostatectomy Epidemiologic significance of annual changes. J Urol. 160:1998;2412-2417
10. Stephenson R.A., Smart C.R., James B.C., et al. The fall in incidence of prostate carcinoma On the down side of a prostate specific antigen induced peak in incidence - data from the Utah Cancer Registry. Cancer. 77:1995;1342-1348
11. Soh S., Kattan M.W., Berkman S., et al. Has there been a recent shift in the pathological features and prognosis of patients treated with radical prostatectomy? J Urol. 157:1997;2212-2218
12. Stephenson R.A. Population-based prostate cancer trends in the PSA era data from the SEER program. Monogr Urol. 19:1998;1-24
13. Epstein J.I., Partin A.W., Sanregeot J., et al. Prediction of progression following radical prostatectomy a multivariate analysis of 721 men with long-term follow-up. Am J Surg Pathol. 20:1996;286-292
14. Pound C.R., Partin A.W., Epstein J.I., et al. Prostate-specific antigen after anatomic radical retropubic prostatectomy patterns of recurrence and cancer control. Urol Clin North Am. 24:1997;395-406
15. Kupelian P., Katcher J., Levin H., et al. Correlation of clinical and pathologic factors with rising PSA profiles after radical prostatectomy alone for clinically localized prostate cancer. Urology. 48:1996;249-260
16. Partin A.W., Pound C.R., Clemens J.Q., et al. Prostate-specific antigen after anatomic radical prostatectomy The John Hopkins experience after ten years. Urol Clin North Am. 20:1993;713-725
17. Catalona W.J., Smith D.S. 5-year tumor recurrence rates after anatomical radical retropubic prostatectomy for prostate cancer. J Urol. 152:1994;1837-1842
18. Ohori M., Goad J.R., Wheeler T.M., et al. Can radical prostatectomy alter the progression of poorly differentiated prostate cancer? J Urol. 153:1994;1160-1163
19. Zinke H., Oesterling J.E., Blute M.L., et al. Long-term (15 years) results after radical prostatectomy for clinically localized (stage T2c or lower) prostate cancer. J Urol. 152:1994;1850-1857
20. Hall G.S., Kramer C.E., Epstein J.I. Evaluation of radical prostatectomy specimens a comparative analysis of various sampling methods. Am J Surg Pathol. 16:1992;315-324
21. Cagiannos I., Graefen M., Karaklewicz P.I., et al. Analysis of clinical stage T2 prostate cancer do current subclassifications represent an improvement? J Clin Oncol. 20:2002;2025-2030
22. Klein E.A. Early continence after radical prostatectomy. J Urol. 148:1992;92-94
23. Klein E., Kupelian P., Tuason L., et al. Initial dissection of the lateral fascia reduces the positive margin rate in radical prostatectomy. Urology. 51:1998;766-773
24. The one-way layout. Hollander M., Wolfe D.A. Nonparametric Statistical Methods. 1973;120-123 Wiley, New York
25. Mettlin C., Murphy G.P., Babaian R.J., et al. The results of a five-year early prostate cancer detection intervention Investigators of the American Cancer Society National Prostate Cancer Detection Project. Cancer. 77:1996;150-159
26. Murphy G.P., Natarajan N., Pontes J.E., et al. The national survey of prostate cancer in the United States by the American College of Surgeons. J Urol. 127:1982;928-934
27. Paquette E.L., Sun L., Paquette L.R., Connelly R., Mcleod D.G., Moul J.W. Improved prostate cancer-specific survival and other disease parameters impact of prostate-specific antigen testing. Urology. 60:2002;756-759
28. Thompson I.M., Ernst J.J., Gangai M.P., et al. Adenocarcinoma of the prostate results of routine urological screening. J Urol. 32:1984;690-694
29. Ercole C.J., Lange P.H., Mathiesen M., et al. Prostate-specific antigen and prostatic acid phosphatase in the monitoring and staging of patients with prostate cancer. J Urol. 138:1987;1181-1184
30. Stamey T.A., Yang N., Hay A.R., et al. Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate. N Engl J Med. 317:1987;909-916
31. Oesterling J.E., Chan D.W., Epstein J.I., et al. Prostate-specific antigen in the preoperative and postoperative evaluation of localized prostate cancer treated with radical prostatectomy. J Urol. 139:1988;766-772
32. Catalona W.J., Smith D.S., Ratliff T.L., et al. Measurement of prostate-specific antigen in serum as a screening test for prostate cancer. N Engl J Med. 324:1991;1156-1161
33. Partin A.W., Yoo J.K., Carter H.B., et al. The use of prostate-specific antigen, clinical stage and Gleason score to predict pathological stage in men with localized prostate cancer. J Urol. 150:1993;110-114
34. Klein E.A., Kupelian P., Zippe C., et al. Identification of margin negative patients at risk for tumor recurrence after radical prostatectomy. J Urol. 157:1997;388. (abstr)
35. Paquette E.L., Connelly R.R., Sun L., et al. Predictors of extracapsular extension and positive margins in african american and white men. Urol Oncol. 21:2003;33-38
36. Ung J.O., Richie J.P., Chen M.H., et al. Evolution of the presentation and pathologic and biochemical outcomes after radical prostatectomy for patients with clinically localized prostate cancer diagnosed during the PSA era. Urology. 60:2002;458-463
37. Peschel R.E., Colberg J.W. Surgery, brachytherapy, and external-beam radiotherapy for early prostate cancer. Lancet Oncol. 4:2003;233-241
38. Jhaveri F.M., Klein E.A., Kupelian P.A., et al. Declining rates of extracapsular extension after radical prostatectomy evidence for continued stage migration. J Clin Oncol. 17:1999;3167-3172